Comparison of marrow and blood cell yields from the same donors in a double-blind, randomized study of allogeneic marrow vs blood stem cell transplantation

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Bone Marrow Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1038/sj.bmt.1702173PMID 10713626
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

  2000cited by this paper
• Long-term outcome of adult acute leukemia patients who are alive and well two years after allogeneic bone marrow transplantation from an HLA-identical sibling.

  1999cited by this paper
• Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts

  1997cited by this paper
• Prospective, concurrent comparison of the Cobe Spectra and Haemonetics MCS‐3P cell separators for leukapheresis after high‐dose filgrastim in patients with hematologic malignancies

  1997cited by this paper
• Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose.

  1997cited by this paper
• Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation.

  1996cited by this paper
• Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlations with malignancy in Epstein-Barr virus--associated lymphoproliferative disorders and malignant lymphomas.

  1996cited by this paper
• Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.

  1996cited by this paper
• Transfusion requirements after bone marrow transplantation from HLA-identical siblings: effects of donor-recipient ABO incompatibility.

  1996cited by this paper
• Allogeneic blood stem cell transplantation: peripheralization and yield of donor-derived primitive hematopoietic progenitor cells (CD34+ Thy-1dim) and lymphoid subsets, and possible predictors of engraftment and graft-versus-host disease.

  1995cited by this paper
• Transplantation of allogeneic peripheral blood stem cells mobilized by recombinant human granulocyte colony-stimulating factor.

  1995cited by this paper
• Primary transplantation of allogeneic peripheral blood progenitor cells mobilized by filgrastim (granulocyte colony-stimulating factor)

  1995cited by this paper
• Allogeneic blood stem cell transplantation for refractory leukemia and lymphoma: potential advantage of blood over marrow allografts.

  1995cited by this paper
• Bone Marrow and Peripheral Blood Stem Cell Harvesting

  1992cited by this paper
• THE FUTURE OF BONE MARROW TRANSPLANTATION

  1979cited by this paper
• Human bone marrow colony growth in agar‐gel

  1970cited by this paper

• The Day Two Advantage: A Retrospective Paired Analysis of Consecutive HPC(A) Collections

  2025cites this paper
• Fifty years of BMT: risk stratification, donor matching, and stem cell collection for transplantation

  2023cites this paper
• Autoimmune diseases after allogeneic stem cell transplantation: a clinician’s guide and future outlook

  2022cites this paper
• Multi-omic profiling of the leukemic microenvironment shows bone marrow interstitial fluid is distinct from peripheral blood plasma

  2022cites this paper
• Stem cells: a comprehensive review of origins and emerging clinical roles in medical practice.

  2022cites this paper
• Outcomes of Bone Marrow Compared to Peripheral Blood for Haploidentical Transplantation

  2021cites this paper
• Autoimmune cytopenias (AIC) following allogeneic haematopoietic stem cell transplant for acquired aplastic anaemia: a joint study of the Autoimmune Diseases and Severe Aplastic Anaemia Working Parties (ADWP/SAAWP) of the European Society for Blood and Marrow Transplantation (EBMT)

  2019cites this paper
• Impact of conditioning regimen on peripheral blood hematopoietic cell transplant

  2019cites this paper
• Immune responses post haematopoietic stem cell transplant : clinical studies of vaccination and autoimmunity

  2019cites this paper
• From risk indices to reconstitution of immunity : studies of outcome-related factors in patients undergoing allogeneic hematopoietic stem cell transplantation

  2019cites this paper
• Stem Cell Therapy for Fanconi Anemia.

  2018cites this paper
• Stem Cells: Biology and Engineering

  2018cites this paper
• Quantification of variation in biological input materials and its effect on manufacture and process control

  2017cites this paper
• G-CSF inhibits LFA-1-mediated CD4+ T cell functions by inhibiting Lck and ZAP-70.

  2017cites this paper
• Ex Vivo Mesenchymal Precursor Cell-Expanded Cord Blood Transplantation after Reduced-Intensity Conditioning Regimens Improves Time to Neutrophil Recovery.

  2017cites this paper
• G-CSF inhibits LFA-1-mediated CD4+ T cell functions by inhibiting Lck and ZAP-70

  2017cites this paper
• Optimal graft source for allogeneic hematopoietic stem cell transplant: bone marrow or peripheral blood?

  2016cites this paper
• Could stem cells be the future therapy for sepsis?

  2016cites this paper
• Dendritic cell reconstitution is associated with relapse-free survival and acute GVHD severity in children after allogeneic stem cell transplantation

  2015cites this paper
• Effect of Total Nucleated and CD34(+) Cell Dose on Outcome after Allogeneic Hematopoietic Stem Cell Transplantation.

  2015cites this paper
• Managing the potential and pitfalls during clinical translation of emerging stem cell therapies

  2014cites this paper
• Immunotherapy following hematopoietic stem cell transplantation: potential for synergistic effects.

  2010cites this paper
• Manifestations and Treatment of Acute Graft‐versus‐Host Disease

  2009cites this paper
• Optimizing the CD34 + cell dose for reduced-intensity allogeneic hematopoietic stem cell transplantation

  2009cites this paper
• Stem Cell Sources for Allogeneic Transplantation

  2008cites this paper
• Influential Factors for Engraftment in Autologous Peripheral Hematopoietic Stem Cell Transplantation (APBSCT)

  2007cites this paper
• Granulocyte‐colony stimulating factor administration after myocardial infarction in a porcine ischemia‐reperfusion model: Functional and pathological effects of dose timing

  2007influential citation
• Comparison of the Fenwal Amicus and Fresenius Com.Tec cell separators for autologous peripheral blood progenitor cell collection.

  2007cites this paper
• Chapter 39 – Transfusion to Bone Marrow or Solid Organ Transplant Recipients

  2007cites this paper
• Recolección de células hematopoyéticas periféricas para trasplante alogénico con una dosis intermedia de filgrastim

  2007cites this paper
• Cytokines in hematopoietic stem cell transplantation.

  2005cites this paper
• Stem Cell Sources

  2004cites this paper
• Disease‐ or therapy‐related bone marrow damage cannot be overcome by changes in stem cell source or dose in allogeneic transplantation

  2004cites this paper
• Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?

  2004cites this paper
• No predictive value of cytotoxic or helper T-cell precursor frequencies for outcome when analyzed from the graft after stem cell transplantation

  2004cites this paper
• The whys and hows of hematopoietic progenitor and stem cell mobilization

  2003cites this paper
• Autologous recovery with protractedly undetectable donor chimerisms can precede stable donor engraftment in a nonmyeloablative cord blood transplant

  2003cites this paper
• Marrow versus peripheral blood for geno-identical allogeneic stem cell transplantation in acute myelocytic leukemia: influence of dose and stem cell source shows better outcome with rich marrow.

  2003cites this paper
• Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?

  2003cites this paper
• Allogeneic hematopoietic stem cell transplantation for myeloproliferative disorders and myelodysplastic syndromes.

  2003cites this paper
• Matched-pair analysis comparing allogeneic PBPCT and BMT from HLA-identical relatives in childhood acute lymphoblastic leukemia

  2002cites this paper
• Associação da dose de células CD34 com recuperação hematopoética, infecções e outros desfechos após transplante alogênico de medula óssea de doador familiar HLA-idêntico

  2002cites this paper
• Optimizing engraftment--source and dose of stem cells.

  2002cites this paper
• Association of CD34 cell dose with hematopoietic recovery, infections, and other outcomes after HLA-identical sibling bone marrow transplantation.

  2002cites this paper
• Association of CD 34 cell dose with hematopoietic recovery , infections , and other outcomes after HLA-identical sibling bone marrow transplantation

  2002cites this paper
• Peripheral Blood Stem Cells for Allogeneic Transplantation: A Review

  2001cites this paper
• Effect of granulocyte colony-stimulating factor mobilization on phenotypical and functional properties of immune cells.

  2001cites this paper
• No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors.

  2001cites this paper
• Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: a randomised trial.

  2000cites this paper
• A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 × 106 CD34+ cells/kg be considered the minimum threshold?

  2000cites this paper
• Cytofluorometric methods for assessing absolute numbers of cell subsets in blood. European Working Group on Clinical Cell Analysis.

  2000cites this paper
• Long-term follow-up of relapsed acute leukemia treated with immunotherapy after allogeneic transplantation: the inseparability of graft-versus-host disease and graft-versus-leukemia, and the problem of extramedullary relapse.

  1999cites this paper
• Review Reimmunization after blood or marrow stem cell transplantation

  1999cites this paper